1-8 of 8
Martin J.S. Dyer, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Establishment of an In Vivo Mouse Model to Study and Overcome Infusion Related Reactions Associated with Fcgriib Antibody Administration

Ingrid Karlsson, PhD, Linda Mårtensson, PhD, Marie Borggren, PhD, Mathilda Kovacek, Carl Roos, Therese Blidberg, Robert Oldham, PhD, Mats Jerkeman, MD PhD, Martin J.S. Dyer, MD PhD, Andrew Davies, MD PhD, Raul Córdoba, MD PhD, Pau Abrisqueta, MD PhD, Stephen Beers, PhD, Ingrid Teige, PhD, Andres McAllister, MD PhD, Sean H Lim, MD PhD, Mark S Cragg, PhD, Björn Frendéus, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-138658
Published: 2020
Journal Articles

Marked Sensitivity of Chronic Lymphocytic Leukemia (CLL) to Apoptosis Induced by BCL2 Antagonist ABT-737.

Meike Vogler, PhD, Aneela Majid, PhD, Renata Walewska, MD, Martin J.S. Dyer, MD, DPhil, Gerald M. Cohen, PhD
Journal: Blood
Blood (2007) 110 (11): 3105.
https://doi.org/10.1182/blood.V110.11.3105.3105
Published: 2007
Journal Articles

Rituximab-Relapsing Patients with Non-Hodgkins Lymphoma Respond Even at Lower Doses of Humanized Anti-CD20 Antibody, IMMU-106 ( hA 20): Phase I/II Results.

Franck Morschhauser, MD, John P. Leonard, MD, Luis Fayad, MD, Bertrand Coiffier, MD, STephen J. Schuster, MD, Martin J.S. Dyer, MD, Marie-Odile Petillon, MD, Morton Coleman, MD, Amina Bahkti, Heather Horne, Li Xu, MD, Nick Teoh, PhD, William A. Wegener, MD, David M. Goldenberg, MD
Journal: Blood
Blood (2006) 108 (11): 2719.
https://doi.org/10.1182/blood.V108.11.2719.2719
Published: 2006
Journal Articles

Inhibition of Bortezomib-Induced Apoptosis in Chronic Lymphocytic Leukemia by Red Blood Cell Uptake.

Luise M.C. Wheat, PhD, Susan L. Kohlhaas, BSc, Johan Monbaliu, PhD, Roland De Coster, PhD, Aneela Majid, PhD, Renata J. Walewska, MD, Gerald M. Cohen, PhD, Martin J.S. Dyer, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5027.
https://doi.org/10.1182/blood.V106.11.5027.5027
Published: 2005
Journal Articles

Enhanced Potency of Glycoengineered Anti-CD52 Monoclonal Antibodies (MAbs).

Martin J.S. Dyer, MD, PhD, Samuel Moser, PhD, Peter Brünker, PhD, Pru Bird, PhD, Neil Almond, PhD, Ursula Püentener, PhD, Luise M.W. Wheat, PhD, Emma Bolam, Eleanor Berrie, PhD, Roger Grau, PhD, Emma Buckby, Ben Kennedy, MD, Richard Stebbings, PhD, Geoff Hale, PhD, Pablo Umana, PhD
Journal: Blood
Blood (2005) 106 (11): 2958.
https://doi.org/10.1182/blood.V106.11.2958.2958
Published: 2005
Journal Articles

Increasing the Dose Intensity of Alemtuzumab (CAMPATH-1H) in Chronic Lymphocytic Leukemia (CLL): The CAM1515 Study.

Martin J.S. Dyer, MD, PhD, Emma Buckby, Pam Fermahan, Renata Walewska, MD, Ben Kennedy, MD
Journal: Blood
Blood (2005) 106 (11): 2959.
https://doi.org/10.1182/blood.V106.11.2959.2959
Published: 2005
Journal Articles

Involvement of the CEBP Gene Family in Four IGH@ Chromosomal Translocations in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL).

Martin J.S. Dyer, MD, PhD, Takashi Akasaka, MD, PhD, Theodore Balasas, BSc, Lisa Russell, BSc, Kei-Ji Sugimoto, MD, PhD, Aneela Majid, PhD, David G. Brown, BSc, Kelvin Cain, PhD, Jon C. Strefford, PhD, Christine J. Harrison, PhD, Reiner Siebert, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2842.
https://doi.org/10.1182/blood.V106.11.2842.2842
Published: 2005
Journal Articles

Mantle Cell Lymphoma Genotypes Identified with CGH to BAC Microarrays Define Clinical Subgroups of Disease and Strongly Predict Patient Outcome.

Jose A. Martinez-Climent, MD, Fanny Rubio-Moscardo, MSc, Joan Climent, MSc, Maria J. Terol, MD, Elena T. Sarsotti, MSc, Isabel Benet, MD, Reiner Siebert, MD, Miguel A. Piris, MD, Inaki Martin-Subero, MD, Martin J.S. Dyer, MD, Daniel Pinkel, PhD, Javier Garcia-Conde, MD
Journal: Blood
Blood (2004) 104 (11): 695.
https://doi.org/10.1182/blood.V104.11.695.695
Published: 2004